Cell And Gene Therapy Supply Chain/Logistics Market Growth Outlook Through 2024-2033

Overview and Scope
Cell and gene therapy supply chains and logistics refer to the processes and activities involved in efficiently and effectively managing the flow of materials, information, and resources needed to develop, manufacture, and distribute cell and gene therapies from their initial production to their final administration to patients. These services provide cutting-edge treatments to patients while maintaining the highest safety and efficacy standards throughout the supply chain.

Sizing and Forecast
The cell and gene therapy supply chain/logistics market size has grown rapidly in recent years. It will grow from $1.25 billion in 2023 to $1.4 billion in 2024 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to growth in prevalence of chronic diseases, efficient use of supply chain requirements, rise in maintainence the drug integrity, evolved regulatory frameworks, increased emphasis on risk mitigation and compliance.

The cell and gene therapy supply chain/logistics market size is expected to see rapid growth in the next few years. It will grow to $2.15 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to expansion of personalized medicine, development of cell-free therapies, growing prevalence of chronic diseases, growing global cell therapy manufacturing market, efficient use of supply chain requirements. Major trends in the forecast period include increased research and development expenditure, adoption of advanced technologies, favorable initiatives and programs for easier access, partnerships and collaborations between cell and gene therapy companies, supply chain providers, and logistics companies, providing of customizable services to support any point of patient identification.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report

Segmentation & Regional Insights
The cell and gene therapy supply chain/logistics market covered in this report is segmented –

1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution
3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components
4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up
5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization

North America was the largest region in the cell and gene therapy supply chain/logistics market in 2023. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=12631&type=smp

Major Driver Impacting Market Growth
The increasing need for cell and gene therapies is driving the cell and gene therapy supply chain/logistics market. Cell and gene therapies are advanced medical treatments that modify cells or genes to treat diseases, offering potential breakthroughs for untreatable conditions. These cell and gene therapies need to be stored at the proper temperature and storage conditions, which can be achieved using supply chain and logistics services, which help from sourcing to distributing and storing these cell and gene therapies. For instance, in February 2022, according to Cell & Gene, a US-based online resource for research scholars, the private investment in cell and gene therapy in 2021 was $68 billion. Moreover, the number of approved cell and gene therapies experienced a 10% growth in 2021. Therefore, the increasing need for cell and gene therapies drives the cell and gene therapy supply chain/logistics market forward.

Key Industry Players

Major companies operating in the cell and gene therapy supply chain/logistics market report are AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.

The cell and gene therapy supply chain/logistics market report table of contents includes:

1. Executive Summary
2. Cell And Gene Therapy Supply Chain/Logistics Market Characteristics
3. Cell And Gene Therapy Supply Chain/Logistics Market Trends And Strategies
4. Cell And Gene Therapy Supply Chain/Logistics Market – Macro Economic Scenario
5. Global Cell And Gene Therapy Supply Chain/Logistics Market Size and Growth
.
.
.
31. Cell And Gene Therapy Supply Chain/Logistics Market Other Major And Innovative Companies
32. Global Cell And Gene Therapy Supply Chain/Logistics Market Competitive Benchmarking
33. Global Cell And Gene Therapy Supply Chain/Logistics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Cell And Gene Therapy Supply Chain/Logistics Market
35. Cell And Gene Therapy Supply Chain/Logistics Market Future Outlook and Potential Analysis
36.Appendix

Explore the trending research reports from TBRC:

Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model